Emerging Markets And Digital Transformation Will Enable Long-Term Stability

Key Takeaways

• Expansion of reduced-risk products and innovation in emerging markets supports global growth, margin improvement, and earnings resilience.
  
• Digital transformation and cost efficiency drive capital allocation, cash generation, and sustained shareholder returns.
  
• Regulatory, market, and societal pressures threaten revenue stability, margin growth, and long-term business sustainability as BAT transitions from traditional cigarettes to newer product categories.

Catalysts

Provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States.

• The rapid growth and further penetration of Modern Oral (Velo) and Heated Products, especially in emerging markets with rising disposable incomes, positions BAT well to tap into geographic revenue diversification and stabilize global volumes, supporting top-line growth in the medium to long term.
  
• Strong uptake and premiumization of reduced-risk new category products (Modern Oral, Heated, and Vapour), combined with successful innovation rollouts (Velo Plus, glo Hilo, Vuse Ultra), are driving higher contribution margins and gross margins, setting the stage for structural net margin and earnings expansion as these products scale.
  
• Digital transformation, operational streamlining, and targeted cost savings programs (e.g., Fit2Win, global supply chain efficiencies) are releasing capital for reinvestment in high-return growth opportunities and innovation, protecting operating margins and supporting future free cash flow growth.
  
• Proactive adaptation to evolving regulatory environments (e.g., greater enforcement on illicit vapour, prioritizing science-backed engagement) and strategic resource allocation to profitable/favorable markets underpin management's ability to safeguard market share and drive resilience in both existing and new product segments, with the expected effect of stabilizing earnings.
  
• Ongoing strong cash generation, disciplined deleveraging, and a commitment to progressive dividends and share buybacks enhance total shareholder return potential and underpin long-term financial flexibility, likely supporting sustained EPS growth and valuation re-rating as execution continues.

British American Tobacco Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming British American Tobacco's revenue will grow by 2.4% annually over the next 3 years.
• Analysts assume that profit margins will increase from 11.9% today to 30.2% in 3 years time.
• Analysts expect earnings to reach £8.3 billion (and earnings per share of £3.94) by about August 2028, up from £3.0 billion today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 13.0x on those 2028 earnings, down from 30.1x today. This future PE is lower than the current PE for the US Tobacco industry at 20.1x.
• Analysts expect the number of shares outstanding to decline by 1.3% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.16%, as per the Simply Wall St company report.

British American Tobacco Future Earnings Per Share Growth

Risks

• Escalating regulatory risk and fiscal headwinds in key markets-such as flavor bans, strict enforcement inconsistency, and increased excise taxes (e.g., Bangladesh, Australia, Canada, and Malaysia)-continue to impact legal product availability and sales, particularly in vapour, which could erode BAT's revenues and operating margins over time.
  
• Persistent illicit trade in vapour and combustible products, especially in the U.S. and Canada, undermines BAT's legal market share and limits its ability to grow volumes and revenues from both traditional and new category products, thereby putting pressure on revenue growth and earnings stability.
  
• Ongoing secular declines in combustible cigarette volumes, despite near-term stabilization and pricing offsets, represent a fundamental risk to BAT's main revenue base (still >70% from combustibles), potentially leading to long-term revenue contraction and margin pressure as regulatory and public health pressure increases.
  
• High and rising investment in new categories (Modern Oral, Heated, Vape) is required to offset declines in traditional products, yet these segments face intense competition, evolving regulatory hurdles, and inconsistent execution-risking lower-than-expected returns on investment, reduced profitability, and more volatile earnings.
  
• ESG-related investor aversion and growing health consciousness may limit BAT's access to certain pools of institutional capital, suppress share valuations, and shrink the overall addressable market over the longer term, affecting both net margins and enterprise value.

Valuation

• The analysts have a consensus price target of £40.667 for British American Tobacco based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £52.0, and the most bearish reporting a price target of just £26.5.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be £27.4 billion, earnings will come to £8.3 billion, and it would be trading on a PE ratio of 13.0x, assuming you use a discount rate of 8.2%.
• Given the current share price of £42.0, the analyst price target of £40.67 is 3.3% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.